Elite Research USA
Verified COAs, mixed Finnrick footprint
Verdict
Uses Freedom Diagnostics (Franklin, TN) and BioRegen as named third-party testing labs, with COAs verifiable through their respective public lookups. Every COA includes HPLC purity + Mass Spectrometry identity, is lot-specific (e.g., BPC-157 Lot 5397AN1225 at 99.092% purity), and is signed by a named principal chemist. Endotoxin testing is performed for nearly all products, not just GLP-1s. The testing infrastructure is real and well-built. The friction shows up in Finnrick's 47-sample independent verification across 7 products: HPLC purity is consistently 99%+ on every Finnrick sample, but fill-mass variance ranges from -12.2% underfill to +13.0% overfill across recent tests, and BPC-157 plus CJC-1295 both carry Finnrick's E Bad rating. Quality is the result of QC inconsistency at fill rather than peptide-quality failure.
Documented strengths
- Two named third-party labs: Freedom Diagnostics (Franklin, TN) and BioRegen
- Both labs use HPLC + Mass Spec analytical methodology
- COAs verifiable directly via Freedom Diagnostics public lookup
- Lot-specific COAs with batch numbers and search codes
- Signed by principal chemist, full traceability
- Endotoxin testing per USP <85> performed for nearly all products, not just GLP-1s
- Substantial Finnrick exposure: 47 samples across 7 products demonstrates depth of independent verification
- HPLC purity itself consistently strong (99.13-99.70% across all visible Finnrick samples)
- US-based, domestic shipping with credit card checkout
- Wide catalog including newer GLP-1 analogs (Mazdutide) and rare research compounds
Considerations
- Endotoxin testing covers nearly all products but is not fully universal across the entire catalog
- No heavy metals testing on any COA
- No sterility (USP <71>) testing on any COA
- Mixed Finnrick footprint across 47 samples / 7 products: BPC-157 and CJC-1295 both rated E Bad and Tirzepatide D Poor, the GLP-1 portfolio (Mazdutide, Retatrutide, Semaglutide) sits at C Okay, and only Melanotan II reaches B Good. HPLC purity is consistently strong (99.13-99.70%); the failures trace to fill-mass variance (-12.2% underfill to +13.0% overfill vs label) rather than peptide-quality problems
- No multi-vial conformity sampling on COAs
- No dedicated COA archive page on the site. COAs accessible only via Freedom Diagnostics portal lookup with batch numbers, requiring buyer initiative rather than at-a-glance browsability
- Only 3 Trustpilot reviews, very limited external validation footprint
- Documented Trustpilot incident: Enclomiphene order shipped as DMAA (a banned stimulant). Buyer reportedly consumed it before noticing the mix-up; resolution path not documented in the public review
- Separate Trustpilot complaint reports HCG product underdosed per buyer independent testing; customer service response described as dismissive (told buyer no one else complained and recommended different injection technique rather than addressing the underdosing claim)
- Founder/owner identity not disclosed publicly
- Legal entity not disclosed publicly
- Manufacturer relationship not disclosed
- Physical address not disclosed on the public site
- Operational history relatively short
- No Janoshik direct submissions identified
Vendor facts
Tests reported
Summary
A vendor with genuine third-party testing infrastructure spanning two named labs (Freedom Diagnostics + BioRegen), verifiable COAs, and HPLC purity that holds up well under independent Finnrick scrutiny. The friction is consistent: fill-mass QC is variable enough to land BPC-157 and CJC-1295 at Finnrick E Bad rating despite clean purity numbers, and the testing scope is narrower than peer set on contaminant categories (no heavy metals, no sterility). Best positioned for buyers comfortable with confirmed identity and purity who do not need precise dose-mass accuracy. Less well positioned for buyers prioritizing dosing precision on staple peptides like BPC-157 or CJC-1295.